Julie Fotheringham

[Julie Fotheringham @HagemanComm]

Interface Biologics Announces Spinout, Ripple Therapeutics https://t.co/0jM5PPopK2

[Soricimed Biopharma Inc. @Soricimed]

Soricimed is developing the next generation of PDCs for cancer treatment by linking cytotoxic payloads to its proprietary TRPV6-targeting peptides. #oncology #PeptideDrugConjugate #cancertherapy https://t.co/OCglZtUIpX

[Brett Ruskin @Brett_CBC]

A half-century ago, five murals in a Halifax church were painted over with white paint. This year, the artwork has been revealed... along with the reason it was covered.

[Julie Fotheringham @HagemanComm]

Soricimed’s platform of unique peptides making waves in cancer and beyond https://t.co/48KDTf0yyR

[Interface Biologics @InterfaceBiolog]

Our V.P. R&D @NaimarkWendy delivers Retinal Drug Delivery Solutions at OIS@ASRS 2019 #drugdelivery #ophthalmology #OIS #ASRS Watch here https://t.co/0u1RvBCTTL

[Erin O'Toole @erinotoole]

My Conservatism is grounded in my upbringing

[Julie Fotheringham @HagemanComm]

Soricimed Announces Initiation of Patient Dosing for First Cohort in Investigator-Initiated Phase 1b Clinical trial of SOR-C13 https://t.co/EW5D2eiyzg

[Julie Fotheringham @HagemanComm]

Soricimed and Image Analysis Group Partner to Validate Predictive Imaging Markers for SOR-C13 Treatment Response in Solid Cancer Tumors https://t.co/uDSrJTwlFq

[Julie Fotheringham @HagemanComm]

Soricimed Announces Investigator Initiated Phase 1b Clinical trial of its Lead Drug Candidate in Late-Stage Pancreatic Cancer https://t.co/5aYzElZFO1

[Julie Fotheringham @HagemanComm]

Soricimed Announces the Appointment of Robert Bruce as Chief Executive Officer https://t.co/dCYRsMlalO

[BioTuesdays @BioTuesdays]

This week's Feature - @InterfaceBiolog to focus future growth in biotech with local drug delivery platform #drugdevelopment #drugdelivery #ophthalmology

Read the full story - https://t.co/CZ4mU0uTIg

[Julie Fotheringham @HagemanComm]

IBI - an incredibly innovative material science company out of MaRS - expands into pharma applications. #Ophthalmology #drugdelivery #antiinflammatory

[Interface Biologics @InterfaceBiolog]

Interface Biologics Completes Pre-IND Meeting with U.S. FDA on Epidel® Technology for treatment of Posterior Inflammatory Eye Diseases #drugdevelopment #drugdelivery #ophthalmology

https://t.co/MlU7ZUsE0L

[Rebecca O'Toole @RebeccaOToole1]

So proud of @ErinOTooleMP today. Sam Sharpe’s sculpture will finally hang in the House of Commons where it rightfully belongs. Mental health at War is as important as physical wounds. This is politics at it’s best- good people working together regardless of party.

[Julie Fotheringham @HagemanComm]

#BMOforWomen with @AlexaColenbran1

[Queen's University @queensu]

With the support of mentors, staff and faculty members, @LoranScholar recipients at #queensu, like @CallenHageman, are making an impact at the university and around the world https://t.co/6LKrvPGRGE

[Peter Bethlenfalvy @PBethlenfalvy]

Great to see so many smiling young faces at the Uxbridge Santa Claus Parade. #Uxbridge #onpoli #PCPO

[Peter Bethlenfalvy @PBethlenfalvy]

Great to support & honour our veterans at @tplfoundation with @brownbarrie & @ErinOTooleMP Congrats to 2017 Patriot Award recipient Hilary Weston.

[Pope Francis – ARCHIVE @Pontifex266Arch]

Let us all work together to promote peace among peoples and guarantee respect for human rights.

[Julie Fotheringham @HagemanComm]

Interface Biologics Enters Neurology Market - https://t.co/hXqnwVN88o

[Interface Biologics @InterfaceBiolog]

Arkis BioSciences® Achieves FDA Clearance of its CerebroFlo™ EVD Catheter with @InterfaceBiolog Endexo® Technology https://t.co/VvySYy2RFS